Institutional Biosafety Committee (IBC)
The IBC is responsible for monitoring and ensuring compliance as well as review and approval of all research projects that involve recombinant DNA materials. CMU is actively committed to preserving the health and safety of its students, staff, and faculty, and to protecting the environment and the community. It is recognized that use of potentially pathogenic microorganisms and organisms containing recombinant DNA is necessary in many CMU research and teaching laboratories. To ensure the safe handling of these organisms, Carnegie Mellon University (CMU) requires that all research involving rDNA or hazardous biological materials or toxins conducted at CMU shall be conducted in accordance with federal and state laws.
Forms
- rDNA Application for Review of a new rDNA project for IBC review - CMU_IBC_Application
- rDNA Protocol Modification Form - for modifying an existing approved IBC application - CMU_IBC_Protocol_Modification
- rDNA Renewal Form for continuation of a currently approved IBC application - IBC Renewal
- rDNA Request for Exemption from the NIH Guidelines for Research Involving Recombinant DNA (rDNA) Molecules - rDNA Exemption form
Download the desired form. Complete the form and email it along with a biography of all users to: rdna-review@andrew.cmu.edu
Training and rDNA information
Documentation of previous training and refresher training is required prior to conducting procedures involving rDNA. The CMU biosafety officer will provide individual training specifically tailored to your needs. Contact information for CMU's biosafety officer can be found at this CMU link
Biosafety Links
- Office of Biotechnology Activities (OBA) - OBA_link
- NIH Guidelines for Recombinant DNA - NIH rDNA Link
- NIH Biological Decontamination - NIH link
- Risk Group and Biosafety Level Containment Chart - BSL_Charg pdf
- Code of Federal Regulations - CFR Link
- Center for Biologics Evaluation and Research (CBER) - CBER Link
- American Biological Safety Association - ABSA link
